New evidence, new controversies: A critical review of the European society of cardiology 2010 clinical practice guidelines on atrial fibrillation;Nuevas evidencias, nuevas controversias: análisis crítico de la guía de práctica clínica sobre fibrilación auricular 2010 de la Sociedad Europea de Cardiología

Revista Espanola de Cardiologia

Volumn 65, Issue 1, 2012, Pages 7-13

  Anguita, Manuel ^a,b,c   Worner, Fernando ^a,b,c   Domenech, Pere ^b   Marín, Francisco ^b   Ortigosa, Javier ^b   Pérez Villacastín, Julián ^b   Fernández Ortiz, Antonio ^c   Alonso, Angel ^c   Cequier, Angel ^c   Comín, Josep ^c   Heras, Magda ^c   Pan, Manuel ^c   Alzueta, Javier ^d   Arenal, Angel ^d   Barón, Gonzalo ^d   Borrás, Xavier ^d   Bover, Ramón ^d   De La Figuera, Mariano ^d   Escobar, Carlos ^d   Fiol, Miguel ^d   Herreros, Benito ^d   Merino, José L ^d   Mont, Lluis ^d   Murga, Nekane ^d   Pedrote, Alonso ^d   Quesada, Aurelio ^d   Ripoll, Tomás ^d   Rodríguez, José ^d   Ruiz, Martín ^d   Ruiz, Ricardo ^d   more..

^a Sociedad Española de Cardiología ^*  (Spain)

^b Grupo de Trabajo Sobre Guías de Fibrilación Auricular   (Spain)

^c NONE   (Spain)

^d Grupo de Expertos Revisores Del Documento Sobre Guías de Fibrilación Auricular   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLOGY; EVIDENCE BASED PRACTICE; HEART ATRIUM FIBRILLATION; MEDICAL SOCIETY; PRACTICE GUIDELINE; REVIEW;

EID: 84655167658     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2011.10.003     Document Type: Article

References (43)

1. M. Anguita, A. Fernández-Ortiz, F. Worner, A. Alonso, A. Cequier, and J. Comín La Sociedad Española de Cardiología y las guías de práctica clínica de la SEC: hacia una nueva orientación Rev Esp Cardiol 64 2011 795 796
2. A.J. Camm, P. Kirchhof, G.Y. Lip, U. Schotten, I. Savelieva, and S. Ernst Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2010 2369 2429
3. J. Camm, P. Kirchhof, G. Lip, U. Schotten, I. Savelieva, and S. Ernst Guías de práctica clínica para el manejo de la fibrilación auricular Rev Esp Cardiol 63 2010 1483.e1 1483.e83
4. V. Fuster, L.E. Rydén, D.S. Cannom, H.J. Crijns, A.B. Curtis, K.A. Ellenbogen Task Force on Practice Guidelines, American College of Cardiology/American Heart Association; Committee for Practice Guidelines, European Society of Cardiology; European Heart Rhythm Association; Heart Rhythm Society ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines Eur Heart J 27 2006 1979 2030 (Pubitemid 44313588)
5. A.M. Gillis, A.C. Skanes CCS Atrial Fibrillation Guidelines Comité Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Implementing GRADE and Achieving Consensus Can J Cardiol 27 2011 27 30
6. L.S. Wann, A.B. Curtis, C.T. January, K.A. Ellenbogen, J.E. Lowe, N.A. Estes 3rd ACCF/AHA Task Force Members 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 123 2011 104 123
7. A. Banerjee, F. Marín, and G.Y. Lip The improved but unfinished business of stroke risk stratification in atrial fibrillation Rev Esp Cardiol 64 2011 639 641
8. G.Y. Lip, R. Nieuwlaat, R. Pisters, D.A. Lane, and H.J. Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation Chest 137 2010 263 272
9. T.P. Van Staa, E. Setakis, G.L. Di Tanna, D.A. Lane, and G.Y.H. Lip A comparison of risk stratification schemes for stroke in 79884 atrial fibrillation patients in general practice J Thromb Haemost 9 2011 39 48
10. M.C. Fang, D.E. Singer, Y. Chang, E.M. Hylek, L.E. Henault, and N.G. Jensvold Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the ATRIA Study Circulation 112 2005 1687 1691
11. L.Y. Ho, C.W. Siu, W.S. Yue, C.P. Lau, G.Y. Lip, and H.F. Tse Safety and efficacy of oral anticoagulation therapy in Chinese patients with concomitant atrial fibrillation and hypertension J Hum Hypertens 25 2011 304 310
12. J.B. Olesen, G.Y.H. Lip, M.L. Hansen, P.R. Hansen, J.S. Tolstrup, and J. Lindharsen Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study BMJ 342 2011 d124
13. D. Poli, G.Y. Lip, E. Antonucci, E. Grifoni, and D. Lane Stroke risk stratification in a "real-world" elderly anticoagulated atrial fibrillation population J Cardiovasc Electrophysiol 22 2011 25 30
14. J.A. Cairns, S. Connolly, S. McMurtry, M. Stephenson CCS Atrial Fibrillation Committee Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention of Stroke and Systemic Thromboembolism in Atrial Fibrillation and Flutter Can J Cardiol 27 2011 74 90
15. L.H. Rasmussen, T.B. Larsen, K.M. Due, A. Tjønneland, K. Overvad, and G.Y. Lip Impact of vascular disease in predicting stroke and death in patients with atrial fibrillation: the Danish Diet. Cancer and Health cohort study J Thromb Haemost 9 2011 1301 1307
16. L.V. Andersen, L.S. Mortensen, G.Y. Lip, J.S. Lindholt, O. Faergeman, and E.W. Henneberg Atrial fibrillation and upper limb thromboembolectomy: a national cohort study J Thromb Haemost 9 2011 1738 1743
17. R. Pisters, D.A. Lane, R. Nieuwlaat, C.B. De Vos, H.J. Crijns, and G.Y. Lip A novel user-friendly score (HAS-BLED) to asses one-year risk of major bleeding in atrial fibrillation patients: the Euro Herat Survey Chest 138 2010 1093 1100
18. J.B. Olesen, G.Y. Lip, J. Lindhardsen, D.A. Lane, O. Ahlehoff, and M.L. Hansen Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: a net clinical benefit analysis using a 'real world' nationwide cohort study Thromb Haemost 106 2011 739 749
19. 2-VASc en pacientes con riesgo embólico bajo-intermedio Rev Esp Cardiol 2011 10.1016/j.recesp.2011.05. 021
20. S.J. Connolly, M.D. Ezekowitz, S. Yusuf, J. Eikelboom, J. Oldgren, and A. Parekh Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
21. L.S. Wann, A.B. Curtis, K.A. Ellenbogen, N.A. Estes 3rd, M.D. Ezekowitz, W.M. Jackman American College of Cardiology Foundation/American Heart Association Task Force 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines Circulation 123 2011 1144 1150
22. S.J. Connolly, J. Eikelboom, C. Joyner, H.C. Diener, R. Hart, S. Golitsyn AVERROES Steering Committee and Investigators Apixaban in patients with atrial fibrillation N Engl J Med 364 2011 806 817
23. I. Ahrens, G.Y.H. Lip, and K. Peter What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation? Thromb Haemost 105 2011 574 578
24. C.B. Granger, J.H. Alexander, J.J. McMurray, R.D. Lopes, E.M. Hylek, M. Hanna the ARISTOTLE Committees and Investigators Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 2011 981 992
25. M. Joner, A.V. Finn, A. Farb, E.K. Mont, F.D. Kolodgie, and E. Ladich Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 2006 193 202 (Pubitemid 43929240)
26. AFFIRM Investigators A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825 1833
27. I.C. Van Gelder, V.E. Hagens, H.A. Bosker, H. Kingma, O. Kamp, and T. Kingma A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation N Engl J Med 347 2002 1834 1840 (Pubitemid 35417774)
28. D. Roy, M. Talajic, S. Nattel, D.G. Wyse, P. Dorian, and K.L. Lee Rhythm control versus rate control for atrial fibrillation and heart failure N Engl J Med 358 2008 2667 2677 (Pubitemid 351860859)
29. S.H. Hohnloser, K.H. Kuck, and J. Lilienthal Rhythm or rate control in atrial fibrillation. Pharmacological intervention in atrial fibrillation (PIAF): a randomised trial Lancet 356 2000 1789 1794
30. J. Carlsson, S. Miketic, J. Windeler, A. Cuneo, S. Haun, and S. Micus Randomized trial of rate-control in persistent atrial fibrillation J Am Coll Cardiol 41 2003 1690 1696
31. A.J. Camm, G. Breithardt, H. Crijns, P. Dorian, P. Kowey, and J.Y. Le Heuzey Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation) J Am Coll Cardiol 58 2011 493 501
32. S.H. Hohnloser, H.J. Crijns, M. Van Eickels, C. Gaudin, R.L. Page, and C. Porp-Pedersen Effect of dronedarone on cardiovascular events in atrial fibrillation N Engl J Med 360 2009 668 678
33. I.C. Van Gelder, H.F. Groenveld, H.J. Crijns, Y.S. Tuininga, J.G. Tijssen, and A.M. Alings Lenient versus strict rate control in patients with atrial fibrillation N Engl J Med 362 2010 1363 1373
34. A.M. Gillis, A. Verma, M. Talajic, S. Nattels, P. Dorian CCS Atrial Fibrillation Committee Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Rate and Rhythm Management Can J Cardiol 27 2011 47 59
35. J. Le Heuzey, G.M. De Ferrari, D. Radzik, M. Santini, J. Zhu, and J.M. Davy A short-term, ramdomized, double-blind, parallel group study to evaluate the efficacy and safety of dronedorone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study J Cardiovasc Electrophysiol 21 2010 597 605
36. B.N. Singh, S.J. Connolly, H.J. Crijns, D. Roy, P.R. Kowey, and A. Capucci Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter N Engl J Med 357 2007 987 999 (Pubitemid 47367078)
37. L. Kober, Porp-Pedersen Ch, J.J. McMurray, O. Gotzsche, S. Lévy, and H. Crijns Increased mortality after dronedarone therapy for severe heart failure N Engl J Med 358 2008 2678 2687 (Pubitemid 351860860)
38. Dronedarone (Multaq) Study for Permanent AF Stopped Early. Disponible en: http://cardiobrief.org/2011/07/07/dronedarone-multaq-study-for-permanent-af- stopped-early/
39. L. Benito, J. Hoyo, A. Montroig, B. Fornés, G. Flux, and D. Martí Estudio sobre los efectos adversos de los fármacos antiarrítmicos en pacientes con fibrilación auricular atendidos en un Centro de Atención Primaria Med Clin (Barc) 137 2011 241 246
40. L. Van Revén, and M.J. Schalij Amiodarone: an effective antiarrhythmic drug with unusual side effects Heart 96 2010 1593 1600
41. ®): conclusiones de la revaluación de su relación beneficio-riesgo [nota informativa 16/2011]. Disponible en: http://www.aemps.gob.es/informa/notasInformativas/ medicamentosUsoHumano/seguridad/2011/NI-MUH-16-2011.htm
42. A.J. Camm, A. Capucci, S.H. Hohnloser, C. Torp-Pedersen, I.C. Van Gelder, B. Mangal AVRO Investigators A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation J Am Coll Cardiol 57 2011 313 321
43. C. Herrera, T. Deneke, M. Hocini, H. Lehrman, D. Shin, and S. Miyazaki Incidence of asymptomatic intracranial embolic events after pulmonary vein isolation: comparison of different atrial fibrillation technologies in a multicenter study J Am Coll Cardiol 58 2011 681 688